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Introduction
After myocardial infarction (MI), sympathetic hyperactivity, inflammatory responses, including increases in pro-inflammatory cytokines [e.g. tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6)] and activation of angiotensin II (Ang II)-type 1 receptor (AT 1 R) signalling in the infarct, peri-infarct and non-infarct areas of the left ventricle (LV) (Nio et al. 1995; Ono et al. 1998) , contribute to cardiomyocyte apoptosis, fibrosis and progressive LV remodelling and dysfunction (Sam et al. 2000; Sutton & Sharpe, 2000; Palojoki et al. 2001; Rafatian et al. 2014) .
Exercise training improves quality of life and reduces the risk of hospital admissions in patients with heart failure (HF) by decreasing neurohormonal activity and improving cardiorespiratory fitness (Gielen et al. 2015) . Early initiation of exercise training post MI in rodents downregulates the expression of angiotensin-converting enzyme (ACE) and AT 1 R protein (Xu et al. 2008a,b) and reduces TNF-α, IL-1β and IL-6 mRNA in the LV (Puhl et al. 2015) . Exercise training post MI increases anti-apoptotic factor Bcl-2 protein and decreases pro-apoptotic factors Bax and caspase-3 protein in the LV (Lu et al. 2015) . Exercise attenuates the progressive cardiac remodelling and decrease in ejection fraction (EF) post MI (Xu et al. 2008a,b) . The peripheral stimuli induced by exercise that trigger these beneficial effects of exercise training on the heart are still unclear.
In rats, brain-derived neurotrophic factor (BDNF) protein is transiently increased in cardiomyocytes in infarct and peri-infarct areas early post MI (Hong et al. 2014) and in the whole LV at 6 weeks post MI (Katare et al. 2009 ). Cardiac BDNF may play a cardioprotective role post MI by inhibiting apoptosis in ischaemic myocardium. In mice, intramyocardial injection of recombinant BDNF (1 day before MI) increased Bcl-2 mRNA and protein expression, and attenuated increases in terminal deoxynucleotidyl transferased UTP nick end labelling (TUNEL)-positive cells and caspase-3 activity in cardiomyocytes at 3 days post MI. This treatment with BDNF also reduced infarct size by 40% and improved EF by 30% at 3 days post MI (Hang et al. 2015) . In contrast, deletion of cardiomyocyte-specific tropomyosin-related kinase B (TrkB), the binding receptor of BDNF, further increased fibrosis and TUNEL-positive cardiomyocytes in the peri-infarct area of the LV at 2 weeks post MI, and further decreased EF by 20% (Okada et al. 2012) . These results suggest that activation of cardiac BDNF-TrkB signalling attenuates cardiomyocyte apoptosis and improves cardiac function post MI.
It is well established that exercise training increases BDNF expression in the hippocampus (Neeper et al. 1996; Fang et al. 2013; Wrann et al. 2013) , which plays a beneficial role for learning and memory (Vaynman et al. 2004; Griffin et al. 2009 ). The increase in hippocampal BDNF after exercise training appears to be initiated by upregulation of fibronectin type III domain-containing protein 5 (FNDC5) in the hippocampus, possibly by the myokine irisin released into the circulation from skeletal muscle FNDC5 (Wrann et al. 2013) . In skeletal muscle, BDNF is released by contracting muscle cells and improves skeletal muscle metabolism by increasing fat oxidation (Matthews et al. 2009 ), but it is unknown whether this increase is FNDC5 dependent. FNDC5 mRNA is also highly expressed in normal hearts (Wrann et al. 2013 ), but its function in adult hearts and its relationship with cardiac BDNF have not yet been investigated. Whether exercise training in animals with HF post MI affects FNDC5, BDNF and TrkB expression in skeletal muscle and the heart and whether these changes contribute to attenuating progressive cardiac dysfunction is unknown. Skeletal muscle is the principal contributor to exercise-induced physiological adaptations (Egan & Zierath, 2013) , and FNDC5 in skeletal muscle might be the primary stimulus for exercise-induced changes in BDNF not only in the hippocampus, but also in skeletal muscle and the heart. We hypothesized that exercise training post MI increases in parallel FNDC5 and BDNF expression in skeletal mucle and the heart, and the increase in cardiac BDNF correlates with the improvement in cardiac function by exercise.
The aims of the study were therefore to determine the following: (i) the time course of changes in FNDC5, BDNF and TrkB in the heart at 2 and 5 weeks post MI; and (ii) the effects of exercise training on cardiac function and on FNDC5, BDNF and TrkB mRNA and protein in skeletal muscle and the heart post MI. Exercise training was done for 4 weeks, which is commonly used for rats . In the LV, FNDC5, BDNF and TrkB expression was measured separately in non-infarct, peri-infarct and infarct areas because regional differences exist in gene expression between peri-infarct and remote non-infarct regions during LV remodelling post MI (Loennechen et al. 2001) .
Methods

Ethical approval
All experiments were approved by the University of Ottawa Animal Care Committee and conform to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (8th edition, 2011).
Animals
Male Wistar rats weighing 200-250 g (Charles River, Montreal, QC, Canada) were allowed to acclimate for 5-7 days in a room maintained at a constant temperature and humidity. Rats were housed under a 12 h-12 h H. W. Lee and others light-dark cycle with standard laboratory chow and tap water ad libitum.
For induction of MI, slow-release buprenorphine (1 mg kg −1 ) (Chiron Compounding Pharmacy Inc., Guelph, ON, Canada) was injected S.C. 1-2 h before surgery, which provides adequate analgesia for 3 days. Anaesthesia was induced with a 2% mixture of isoflurane and oxygen in a transparent chamber. Anaesthetized rats were intubated with a 51 mm long and 1.7 mm diameter polyethylene tube and connected to a Harvard Rodent Respirator (Harvard Apparatus Co., Holliston, MA, USA) set to a frequency of 75 strokes min −1 of 2.0 ml volume. Thoracotomy was performed via the fourth intercostal space. The pericardium was opened and the left anterior descending (LAD) coronary artery permanently ligated 1-2 mm distal to its origin with a 6-0 silk suture on an atraumatic needle. The fourth and fifth ribs were closed by two separate 4.0 vicryl sutures. Lungs were inflated and air was removed from the thoracic cavity. Isoflurane was stopped and rats remained ventilated with 100% oxygen until waking up or breathing spontaneously. Sham-operated animals underwent a similar procedure except for ligation of the LAD coronary artery. Rats with a small MI (<20% of LV) and minimal or no LV dysfunction at the end of the study were excluded from further analyses.
Experimental groups
The experimental time line is outlined in Fig. 1 . A total of 103 rats were used for this study. For the 5 week study, after LAD coronary artery ligation (n = 56), the 32 surviving MI rats were randomly divided into either a sedentary (Sed-MI) or an exercise group (ExT-MI). Among 17 Sed-MI rats, seven rats had a small MI. Fifteen rats were allocated to ExT-MI, but five rats refused to run and one rat had a small MI (<20% of LV). Rats refusing to run had similar cardiac dysfunction to the overall sedentary group. Therefore, 10 rats for the Sed-MI and nine rats for the ExT-MI group are included in the final analyses for this study. A sedentary sham-operated group (n = 7) served as the control group. To obtain some insights into the time course of cardiac changes post MI, sedentary rats were also studied at 2 weeks post sham or MI surgery. Twenty-seven rats underwent LAD coronary artery ligation and 16 rats survived, of which eight rats had a small MI. Thus, eight rats were included in the MI group and seven rats in the Sham group.
Exercise training protocol and citrate synthase activity assay An exercise programme was conducted for a period of 4 weeks (5 days week −1 ), which is commonly used for rats, as described by Zheng et al. (2012) . The exercise was started 5-7 days after recovery from the chest surgery, and every session was conducted after 12.00 h. For the first 3 days of the first week, rats were trained to exercise on a motor-driven treadmill (Columbus Instruments, Columbus, OH, USA) at low speed (10 m min −1 ), gradient 0%, for a short duration (10-15 min day −1 ) to familiarize the rats with running. On days 4-5 of the first week and second week of exercise, the speed, gradient and duration were gradually increased to 20 m min −1 , 5-10% and 60 min day −1 , respectively. In the third and fourth weeks, maximal levels were maintained constantly. This level of exercise is considered moderate for rats . The sedentary rats were handled daily and treated in a similar manner to the exercising rats except that the treadmill was not put in motion.
To test exercise efficiency, citrate synthase activity was measured spectrophotometrically from homogenates of soleus muscle. Total muscle protein content was determined by the bicinchoninic acid (BCA) assay using bovine serum albumin standards (Thermo Scientific Inc., Rockford, IL, USA). The total reaction mixture was prepared according to the manufacturer's instructions (CS0720; Sigma-Aldrich, St Louis, MO, USA). Baseline absorbance was recorded and reactions were initiated by adding the 10 μl of 10 mM oxaloacetate (OAA), and the change in absorbance was monitored at a wavelength of 410 nm at 25°C at 30 s intervals for a period of 3 min. Citrate synthase activity was measured by calculating the difference in OAA reaction absorbance change to the baseline absorbance change.
Echocardiographic and haemodynamic measurements
Echocardiography was done under 2% isoflurane and oxygen anaesthesia 2-3 h after the last exercise session. A VisualSonic Vevo 770 system (VisualSonics, Toronto, ON, Canada) was used to analyse functional parameters of the heart. In M-mode recording, internal dimensions 
Tissue collection
Trunk blood and tissues (hearts, quadriceps and soleus muscle) were collected the day after haemodynamic measurements, within 48 h of the last exercise session. After decapitation, trunk blood was collected into a prechilled 50 ml conical tube containing heparin. Blood was centrifuged at 1,935 g at 4°C for 30 min and plasma collected for BDNF assay. The hearts were immediately removed and placed in ice-cold saline. The right ventricle (RV) was separated from the LV. The LV was opened flat through a long cut on the septum and additional 2-3 small cuts on the apex. The LV was placed under a transparent sheet and its circumference and the MI borders were traced, and then it was snap-frozen in liquid nitrogen. To measure the infarct size, the LV demarcation on the transparent sheet was scanned and its digital image quantified using Image Pro 6.2. The infarct size is expressed as a percentage of the total LV area. Both soleus muscle and quadriceps were selected because skeletal muscle adaptation to exercise differs by muscle fibre types (Egan & Zierath, 2013) . Soleus muscle and quadriceps were snap-frozen in liquid nitrogen. All tissues and plasma samples were stored at −80°C until further analysis.
Isolation of RNA and real-time qPCR for FNDC5, BDNF, TrkB, AT 1 R and TNF-α
The LV was separated into non-infarct (3-4 mm away from infarct area), peri-infarct (1-2 mm away from infarct area) and infarct areas (Rafatian et al. 2014) . Total RNA was extracted from each area of the LV, soleus muscle and quadriceps with 1 ml QIAzol Lysis Reagent (Qiagen Inc., Mississauga, ON, Canada). After DNase I (Thermo Scientific Inc.) treatment, 5 μg of total RNAs were reverse transcribed into cDNA with oligo dT primers (Thermo Scientific Inc.) and Superscript II RNase H reverse transcriptase (Thermo Scientific Inc.) at 42°C for 60 min. The specific primers for phosphoglycerate kinase 1 (PGK1), FNDC5, BDNF, TrkB, AT 1 R and TNF-α (Table 1) were designed based on the published Genbank sequences. Primers and PCR conditions for PGK1 and AT 1 R were the same as previously described (Wang et al. 2010; Chen et al. 2014) . Real-time PCR was performed using LightCycler 480 SYBR Green I (Roche Diagnostics, Laval, QC, Canada). The PCR conditions were set as follows: an initial step at 95°C for 10 min, followed by 45 cycles of denaturation at 95°C for 10 s; annealing for 15 s at 57°C for BDNF and FNDC5, 59°C for TrkB and TNF-α; and extension at 72°C for 15 s.
The standard curve method was used to determine the mRNA levels of FNDC5, BDNF, TrkB, AT 1 R and TNF-α, followed by normalization using the housekeeping gene PGK1. In order to generate the standard curves, the following PCR fragments were amplified: 316 bp PCR fragment corresponding to position 208-523 (FNDC5), 165 bp fragment at 1212-1372 position (BDNF), 197 bp fragment at 1502-1698 position (TrkB), and 113 bp fragment at 542-654 (TNF-α). The PCR products of various genes were purified and then subcloned into pCRII-TA vector (Invitrogen, Burlington, ON, Canada). Plasmid containing target DNA fragment was verified by restriction endonuclease analysis and PCR analysis using specific primers. The concentrations of the plasmids were H. W. Lee and others 2 weeks 50 ± 4 6 0 ± 14 * * n.d. 5 weeks 40 ± 5 6 9 ± 29 * * 52 ± 7 Echocardiographic parameters Systolic diameter (mm) 2 weeks 3.6 ± 0.6 6.3 ± 0.8 * * n.d. 5 weeks 3.5 ± 0.4 7.0 ± 0.9 * * 5.9 ± 1.3 * * Diastolic diameter (mm) 2 weeks 7.1 ± 0.6 9.1 ± 0.7 * * n.d. 5 weeks 7.7 ± 0.6 10.0 ± 0.8 * * 9.4 ± 1.3 * Ejection fraction (%)
2 weeks 77 ± 6 5 6 ± 8 * * n.d. 5 weeks 84 ± 3 5 4 ± 8 * * 65 ± 7 * * † † Haemodynamic parameters LVPSP (mmHg) 2 weeks 115 ± 9 107 ± 10 * * n.d. 5 weeks 117 ± 9 109 ± 5 * * 109 ± 8 LVEDP (mmHg) 2 weeks 2.6 ± 1.3 15.5 ± 4.2 * * n.d. 5 weeks 2.9 ± 1.2 21.2 ± 10 * * 9.9 ± 3. Values are means ± SD. For 2 weeks, Sham, n = 7; and MI, n = 8. For 5 weeks, Sham, n = 7; Sed-MI, n = 10; and ExT-MI, n = 9. Two-way ANOVA was done for time course changes in Sham and MI. For LV weight, group, F = 11.2, P < 0.01; for RV weight, group, F = 11.3, P < 0.01; for systolic diameter, group, F = 139.2, P < 0.001; for diastolic diameter, group, F = 80, P < 0.001; for ejection fraction, group, F = 115.2, P < 0.001; for LVPSP, group, F = 7.8, P < 0.01; for LVEDP, group, F = 61.8, P < 0.001; for dP/dt max , group, F = 77.8, P < 0.001; and for dP/dt min , group, F = 59.4, P < 0.001. None of the group × time point interactions was significant. Time points were significant only for diastolic diameter (F = 10.5, P < 0.01). One-way ANOVA followed by Bonferroni post hoc test was done for the effect of exercise training at 5 weeks post MI. For LV weight, F = 7.4, P < 0.01; for RV weight, F = 4.7, P < 0.05; for systolic diameter, F = 24.0, P < 0.001; for diastolic diameter, F = 9.8, P < 0.01; for ejection fraction, F = 36.1, P < 0.001; for LVEDP, F = 14.4, P < 0.001; for dP/dt max , F = 10.9, P < 0.01; and for dP/dt min , F = 12.5, P < 0.001. * P < 0.05 and * * P < 0.01 versus Sham. † † P < 0.01 versus Sed-MI. Cardiac brain-derived neurotrophic factor post myocardial infarction measured via NanoDrop spectrophotometry at 260 nm. An external standard curve for each gene was created using serial 10-fold dilutions (e.g. from 100 to 0.001 pg μl −1 ) of plasmid in the same real-time PCR conditions. The mRNA expression level of each gene was represented as the ratio of target gene and PGK1. As the PGK1 mRNA level was downregulated in the infarct area, mRNA expression for all areas of the LV is shown as the absolute value of each gene per total 5 μg of RNA initial input used to generate cDNA.
Western blotting
Immunoblotting was performed using 30-50 μg of total protein from each area of the LV, soleus muscle and quadriceps. Samples were homogenized in ice-cold modified RIPA buffer (50 mM Tris pH 8.0, 150 mM NaCl, 0.5% sodium deoxycholate, 1% NP-40, 1 mM EDTA pH 8.0, and 0.1% SDS) containing 1% protease inhibitor cocktail (Sigma-Aldrich). The homogenate was centrifuged at 10,000g for 30 min at 4°C, the supernatant was collected and the protein concentration measured using the BCA assay (Thermo Scientific Inc.). Proteins were separated by SDS-PAGE (12% gel for BDNF, 10% gel for FNDC5 and 8% gel for TrkB), and transferred onto 0.2 μm PVDF membranes (Bio-Rad, Mississauga, ON, Canada). After blocking for 1 h with 5% milk in Tris-buffered saline with Tween-20 (TBST) at room temperature, the membranes were probed with rabbit polyclonal anti-BDNF (1:1000, ANT-010; Alomone Labs, Jerusalem, Israel) or anti-FNDC5 (1:5000, ab174833; Abcam, Toronto, ON, Canada) or anti-TrkB (1:1000, 07-225; Millipore, Toronto, ON, Canada) at 4°C overnight. Then the blots were incubated with goat anti-rabbit IgG-HRP (1:5000, SC-2004; Santa Cruz Biotechnology, Dallas, TX, USA) for 1 h at room temperature. After washing, the blot was developed with Clarity Western ECL Substrate (Bio-Rad) and visualized with a ChemiDoc XRS+ imager (Bio-Rad). Band densities were quantified using Image Lab software (Bio-Rad). The membranes were reprobed with anti-Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (1:10,000, MAB374; Millipore) as a protein loading control. The expression of each protein was calculated as the ratio of its band density relative to the density of the GAPDH band in the same sample. Although GAPDH is a common housekeeping protein to control for protein loading, its level varies in certain diseased tissues (Ferguson et al. 2005) , and we found that GAPDH was significantly downregulated in the infarct area of the LV. Therefore, for the LV, Ponceau S (P7170; Sigma-Aldrich) staining was used to assess equal loading, which is considered more reliable as a loading control than housekeeping protein levels in diseased tissues (Thacker et al. 2016) , and the measured band density for each protein was used.
Plasma BDNF assay
Total BDNF in plasma was measured using a commercial enzyme-linked immunosorbent assay kit (CYT306; Millipore), which has a range of detection from 15 to 1000 pg ml −1 . All samples were measured in duplicate. One hundred microlitres of BDNF standards and plasma samples were added to a 96-well plate, and the plate was incubated overnight at 4°C. After washing the plate with the wash buffer, 100 μl of the diluted biotinylated mouse anti-BDNF monoclonal antibody (1:1000) was added to each well. The plate was incubated at room temperature for 2 h and 100 μl of the diluted streptavidin-HRP conjugate solution (1:1000) was added to each well, then incubated for 1 h. After washing the plate, 100 μl of TMB/E substrate was added to each well. The reaction was stopped with stop solution and the absorbances of BDNF standards and samples were read at 450 nm. A standard curve was plotted as the known concentration of BDNF standards on the x-axis and the corresponding absorbances on the y-axis, and BDNF concentrations in plasma samples were determined.
Statistical analyses
Comparisons between two groups were tested with Student's unpaired t test, and for three or more groups, by one-way ANOVA followed by Bonferroni post hoc test. To compare time course changes (2 and 5 weeks of Sham and Sed-MI groups), two-way ANOVA was done with Bonferroni post hoc test. Correlations analyses were performed by Pearson's correlation analysis. A value of P < 0.05 was considered statistically significant.
Results
Effect of exercise training on cardiac function
At 2 and 5 weeks post MI, body weight did not differ compared with Sham groups (Table 2) . By two-way ANOVA, there were no interactions between the effect Table 3 . FNDC5, BDNF, TrkB, AT 1 R and TNF-α mRNA expression in the LV at 2 and 5 weeks post MI, and effect of exercise training at 5 weeks post MI
MI Sham
Non-infarct Peri-infarct Infarct FNDC5 mRNA per 5 μg RNA (×10 −1 ) 2 weeks 6.1 ± 0.8 5.6 ± 1.4 4.4 ± 1.2 1.9 ± 0.9 * * † † 5 weeks 8.5 ± 1.6 5.4 ± 1.3 * * 3.6 ± 0.9 * * ‡ 1.8 ± 1.1 * * † † BDNF mRNA per 5 μg RNA (×10 −2 ) 2 weeks 16 ± 9.8 12 ± 9.3 18 ± 3.7 8.5 ± 3.5 5 weeks 10 ± 3.7 8.5 ± 3.3 9.3 ± 0.8 8.1 ± 3.3
TrkB mRNA per 5 μg RNA (×10 −3 ) 2 weeks 9.8 ± 2.4 6.5 ± 2.5 10 ± 4.3 23 ± 5.4 * * † † 5 weeks 7.9 ± 2.1 6.2 ± 2.4 9.7 ± 4.2 16 ± 6.8 * * † † AT 1 R mRNA per 5 μg RNA (×10 −2 ) 2 weeks 5.3 ± 1.3 3.4 ± 1.2 7.1 ± 3.2 27 ± 5.5 * * † † 5 weeks 3.1 ± 0.5 Sed-MI 3.3 ± 0.6 5.5 ± 1.3 20 ± 8.2 * * † † ExT-MI 3.8 ± 1.2 6.0 ± 0.9 * * 20 ± 5.8 * *
TNF-α mRNA per 5 μg RNA (×10 −2 ) 2 weeks 1.8 ± 0.7 1.4 ± 0.6 2.1 ± 0.3 2.3 ± 0.5 ‡ ‡ 5 weeks 2.1 ± 0.1 Sed-MI 1.7 ± 0.3 2.4 ± 0.6 † 1.6 ± 0.6 ExT-MI 1.9 ± 0.5 2.8 ± 0.6 1.9 ± 0.6
Abbreviations: Sed-MI, sedentary MI; ExT-MI, exercise MI; AT 1 R, angiotensin II-type 1 receptor; BDNF, brain-derived neurotrophic factor; FNDC5, fibronectin type III domain-containing protein; TNF-α, tumour necrosis factor-α; and TrkB, tropomyosin-related kinase B. Values are means ± SD. For 2 weeks, Sham, n = 7; and MI, n = 8. For 5 weeks, Sham, n = 7; Sed-MI, n = 10; and ExT-MI, n = 9. Two-way ANOVA was done for time course changes in Sham and MI. For FNDC5, group, F = 55.8, P < 0.001; group × time points, F = 4.6, P < 0.01; for BDNF, group, F = 3.2, P < 0.05; time points, F = 10.3, P < 0.01; for TrkB, group, F = 26.3, P < 0.001; time points, F = 4.7, P < 0.05; for AT 1 R, group, F = 85.9, P < 0.001; time points, F = 7.0, P < 0.05; for TNF-α, group, F = 5.0, P < 0.01; and group × time points, F = 3.4, P < 0.05. One-way ANOVA followed by Bonferroni post hoc test was done for the effect of exercise training at 5 weeks post MI in each area of the LV. For AT 1 R, peri-infarct, F = 15.5, P < 0.001; and infarct, F = 16.7, P < 0.001. * * P < 0.01 versus Sham. † P < 0.05 and † † P < 0.01 versus other areas. ‡ P < 0.05 and ‡ ‡ P < 0.01 versus non-infarct area.
of MI and time points on cardiac function. All parameters were significantly different between Sham and MI groups. Both LV and RV weight were increased post MI (Table 2) . Systolic and diastolic diameters were increased by 75-100 and 20-30%, respectively, and EF decreased by 27-34% (Table 2 ). The LVEDP was increased to 15.5 ± 4.2 mmHg at 2 weeks and 21.2 ± 10 mmHg at 5 weeks, and LVPSP, dP/dt max and dP/dt min were decreased, indicating marked cardiac dysfunction post MI. In the ExT-MI group, MI size was somewhat less (not significant) compared with Sed-MI (Table 2 ). In the ExT-MI group, LV weight was increased to a similar extent as Sed-MI, but RV weight was only modestly increased (Table 2) . Left ventricular dimensions tended to be less increased, and EF was significantly less decreased compared with the Sed-MI group (P < 0.05). The increase in LVEDP was markedly attenuated in the ExT-MI group (P < 0.01 versus Sed-MI), but there was no significant effect of exercise on dP/dt max or dP/dt min (Table 2) . These results indicate that exercise training attenuates cardiac dysfunction post MI.
Effect of exercise training on FNDC5, BDNF and TrkB mRNA and protein expression in skeletal muscle
At 5 weeks post MI, in sedentary rats (Sed-MI) the soleus muscle weight did not differ compared with the Sham group ( Table 2 ). The exercise training did not affect body weight or soleus muscle weight (Table 2 ). In the soleus muscle, citrate synthase activity, an indicator of cellular aerobic metabolism, was ß30% higher in ExT-MI compared with sedentary rats (Sham and Sed-MI; P < 0.01 versus Sham and P < 0.05 versus Sed-MI; Table 2 ).
At 5 weeks post MI, in the soleus muscle of sedentary rats, FNDC5 mRNA expression was decreased (P < 0.05), whereas FNDC5 protein was increased eightfold compared with Sham (P < 0.05; Fig. 2A) . BDNF mRNA and mature BDNF (mBDNF) protein, and TrkB mRNA and a truncated form of TrkB protein (TrkB.T1) were not affected ( Fig. 2A) . In the quadriceps, FNDC5 and BDNF mRNA and protein were not different in MI rats compared with Sham (Fig. 2B) . In contrast, TrkB mRNA was threefold higher in Sed-MI (P < 0.05 versus Sham), but TrkB.T1 protein was not changed (Fig. 2B ).
In the soleus muscle, exercise training post MI did not affect the reduction in FNDC5 mRNA and the increase in FNDC5 protein (Fig. 2A) . BDNF mRNA was not altered by exercise, but mBDNF protein was significantly higher than in Sham group (P < 0.05; Fig. 2A ). TrkB mRNA was not affected by exercise training, whereas TrkB.T1 protein was significantly increased compared with Sed-MI (P < 0.05; Fig. 2A ). In the quadriceps, FNDC5 mRNA and protein and BDNF mRNA were unchanged by exercise For mRNA: Sham, n = 7; Sed-MI, n = 10; and ExT-MI, n = 9. For protein, n = 6 per group. Values are means ± SD. Statistical analysis was by one-way ANOVA followed by Bonferroni post hoc test in each area. For FNDC5 mRNA: non-infarct, F = 7.4, P < 0.01; peri-infarct, F = 21.9, P < 0.001; and infarct, F = 61.8, P < 0.001. For FNDC5 protein: infarct, F = 3.0, P = 0.08 (Sham versus all MI, Student's unpaired t test, P < 0.05). * P < 0.05 and * * P < 0.01 versus Sham. Ponceau S staining is shown as the loading control.
training, but mBDNF protein significantly increased by 60% compared with Sed-MI (P < 0.05; Fig. 2B At 2 weeks post MI, FNDC5 mRNA tended to be lower in the peri-infarct area (P = 0.06) and significantly lower in the infarct area compared with Sham and other areas (P < 0.01; Table 3 ). At 5 weeks post MI, FNDC5 mRNA in all areas of the LV was lower than Sham, the most in the infarct area (Table 3 ). In contrast, at 5 weeks post MI, FNDC5 protein was fourfold increased in the infarct area (Fig. 3B) . For BDNF mRNA, no changes were observed at 2 and 5 weeks post MI (Table 3) . At 5 weeks post MI, mBDNF protein in non-and peri-infarct areas was also not changed, but was significantly decreased in the infarct area (Fig. 4B) . TrkB mRNA was increased twofold in the infarct area at both 2 and 5 weeks post MI (P < 0.01 versus Sham and other areas; Table 3 ), and at 5 weeks post MI, TrkB.T1 protein was also increased twofold in the infarct area (P < 0.05 versus Sham; Fig. 5B ). At 2 and 5 weeks post MI, AT 1 R mRNA was markedly increased in the infarct area (P < 0.01 versus Sham and other areas; Table 3 ). TNF-α mRNA was increased in the infarct area compared with the non-infarct area at 2 weeks post MI (P < 0.01; Table 3 ) and higher in the peri-infarct area compared with non-infarct and infarct areas at 5 weeks (Table 3) . Exercise training did not affect the decrease in FNDC5 mRNA or the increase in FNDC5 protein in the infarct area ( Fig. 3A and B) . Exercise training significantly increased BDNF mRNA in the peri-infarct area (P < 0.01) and mBDNF protein in the non-infarct area (P < 0.05) compared with Sed-MI, but did not affect BDNF mRNA or protein in the infarct area ( Fig. 4A and B) . Exercise training had no effect on TrkB mRNA and protein ( Fig. 5A  and B) , as well as AT 1 R and TNF-α mRNA in all areas (Table 3) .
These results indicate that the infarct area shows prominent changes after MI, including an increase in FNDC5 protein and TrkB.T1 protein, but decrease in mBDNF protein. Exercise training post MI does not affect these proteins in the infarct area, but significantly increases mBDNF protein in the non-infarct area.
The mBDNF protein in the non-infarct area was correlated positively with EF (r = 0.76, P < 0.001) and negatively with LVEDP (r = −0.55, P < 0.05; Fig. 6 ). FNDC5 protein was not correlated with BDNF mRNA or protein.
Plasma BDNF in the Sed-MI group was not different from the Sham group, but exercise training tended to increase plasma BDNF (F = 3.2, P = 0.06; Fig. 7 ). Values are means ± SD. Statistical analysis was by one-way ANOVA followed by Bonferroni post hoc test in each area. For BDNF mRNA: peri-infarct, F = 7.6, P < 0.01. For mBDNF protein: non-infarct, F = 5.8, P < 0.05; and infarct, F = 18.6, P < 0.001. * P < 0.05 and * * P < 0.01 versus Sham. a P < 0.05 and b P < 0.01 versus Sed-MI. Ponceau S staining is shown as the loading control.
Discussion
The major findings of the present study are as follows. First, at 5 weeks post MI, FNDC5 protein is increased in the soleus muscle and the infarct area; mBDNF protein is decreased, whereas TrkB.T1 protein is increased in the infarct area. Second, exercise training does not change FNDC5 protein, but increases mBDNF protein in soleus muscle, quadriceps and the non-infarct area of the LV. Exercise training significantly attenuates the decrease in EF and the increase in LVEDP post MI. These improvements are correlated with the increase in mBDNF protein in the non-infarct area of the LV, suggesting that the increase in cardiac BDNF induced by exercise training might contribute to the improvement of cardiac function. The increase in cardiac BDNF after exercise post MI is prominent in the non-infarct area without a parallel increase in FNDC5 protein, indicating that FNDC5 does not regulate BDNF in the heart after MI and exercise training.
FNDC5, BDNF and TrkB in skeletal muscle
Expression levels of FNDC5 in skeletal muscle are regulated by peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α), a transcriptional coactivator which is a key modulator in energy metabolism, and increased by exercise training (Boström et al. 2012) . Indeed, some studies reported 30-40% increases in FNDC5 expression in skeletal muscle by exercise training (Wrann et al. 2013; Norheim et al. 2014) , but others showed no effect (Timmons et al. 2012; Pekkala et al. 2013; Knudsen et al. 2014) . Determinants of these variable responses of FNDC5 expression to exercise training are not readily apparent.
In the present study, there were no changes in FNDC5 mRNA and protein in the quadriceps at 5 weeks post MI. In contrast, Matsuo et al. (2015) reported that FNDC5 mRNA and protein were decreased in the quadriceps at 7 weeks post MI in rats. This difference may reflect the worse severity of the HF in the study by Matsuo et al. (2015) . On the contrary, in the soleus muscle, which is a more oxidative muscle, FNDC5 mRNA was decreased, but FNDC5 protein was markedly increased. The dissociation of FNDC5 mRNA and protein levels may be attributable to changes in skeletal muscle metabolism after MI, such as decreased oxidative capacity and mitochondrial enzyme activity (Garnier et al. 2003) , which may inhibit normal turnover of FNDC5 protein (Vogel et al. 2011) and the higher protein then decreasing mRNA expression. In the present study, exercise did not affect the increased FNDC5 protein in the soleus muscle of MI rats and did not affect FNDC5 in the quadriceps.
BDNF and its binding receptor TrkB are highly expressed in skeletal muscle (Cuppini et al. 2007; Ogborn & Gardiner, 2010) . TrkB.T1, a truncated form of TrkB lacking the tyrosine kinase domain, is mainly expressed in skeletal muscle rather than the full-length form (Sakuma & Yamaguchi, 2011) . BDNF is produced by muscle cells in response to muscle contraction and acts in an autocrine/paracrine manner, but is not released into the circulation (Cuppini et al. 2007; Matthews et al. 2009 ). Muscle BDNF acts locally and increases fat oxidation mediated by AMP-activated protein kinase (AMPK; Matthews et al. 2009 ). In rats, treadmill exercise for 5 days increased BDNF mRNA in soleus muscle (Cuppini et al. 2007 ), but not for 10 days (Ogborn & Gardiner, 2010) . Jimenez-Maldonado et al. (2015) reported higher BDNF mRNA but lower protein in soleus muscle after 8 weeks of high-intensity treadmill exercise, but not after moderate-intensity exercise. These results suggest that moderate chronic exercise training increases BDNF mRNA only transiently, but high-intensity exercise increases it persistently.
Effects of HF on BDNF and TrkB levels in skeletal muscle have not yet been reported. In the present study, at 5 weeks post MI, BDNF mRNA and protein levels were not changed in both soleus muscle and quadriceps, whereas TrkB mRNA, but not the protein, was increased in the quadriceps. Further studies are needed to determine whether changes in BDNF and TrkB levels are dependent on the duration and/or severity of HF. Exercise training increased mBDNF protein in both soleus muscle and quadriceps. This increase in mBDNF protein in skeletal muscle might improve energy metabolism by increasing fat oxidation (Matthews et al. 2009 ). FNDC5 protein was not correlated with BDNF mRNA or protein, suggesting that FNDC5 might not regulate BDNF expression directly.
FNDC5, BDNF and TrkB in the heart
FNDC5 mRNA is highly expressed in hearts of adult mice (Wrann et al. 2013) or rats (present study), but its role in response to physiological/pathological stress, such as exercise and MI, has not yet been studied. In the present study, FNDC5 mRNA was decreased at both 2 and 5 weeks post MI, the most in the infarct area, whereas the FNDC5 protein level was markedly increased only in the infarct area, which is similar to the opposite changes in mRNA and protein in the soleus muscle. An increase in oxidative stress in the infarct area can inhibit proteasome activity, resulting in accumulation of misfolded proteins (Grune et al. 2004) . To understand FNDC5 regulation and function post MI, further investigations could assess which proteasomes contribute to proteolysis of FNDC5 protein (Erickson, 2013) or whether proteolytic cleavage of FNDC5 occurs in the heart. Cardiac BDNF increases rapidly in response to ischaemic injury and might play a protective role by inhibiting cardiomyocyte apoptosis (Okada et al. 2012; Hang et al. 2015) and improving angiogenesis (Cao et al. 2012; Hong et al. 2014) . In the whole LV, mBDNF protein was increased 1 and 6 h post MI in rats (Hang et al. 2015) and was decreased at 1 day to 2 weeks post MI in mice (Okada et al. 2012) . Immunohistochemical staining showed that BDNF protein increased early post MI in cardiomyocytes and was coexpressed with macrophages, which were infiltrated around endothelial cells in periand infarct areas (Hong et al. 2014) . Halade et al. (2013) reported an increase in mBDNF protein in the infarct area on days 1, 3 and 5 and a return to the baseline level on day 7. In the more chronic phase post MI, a fourfold increase in total BDNF (measured by enzyme-linked immunosorbent assay) in the whole LV was reported at 6 weeks post MI (Katare et al. 2009 ). In the present study, BDNF mRNA was not changed in the LV at 5 weeks, whereas mBDNF protein was significantly decreased in the infarct area, suggesting that post-transcriptional mechanisms might be involved in the reduction in mBDNF. MicroRNAs (miRNAs) repress translation or regulate protein degradation at the post-transcriptional level. miRNA-1 and miRNA-210 are highly expressed in cardiomyocytes, target the BDNF gene (Lin et al. 2010; Ma et al. 2015) and may contribute to the decrease in mBDNF protein in the infarct area. In contrast, TrkB mRNA was increased in the infarct area at 2 and 5 weeks post MI, and TrkB.T1 protein at 5 weeks post MI. Likewise, in mice, TrkB protein was markedly increased at 2 weeks post MI (Okada et al. 2012) . In adult hearts, TrkB.T1 protein is the dominant isoform of TrkB, and specific knockout of TrkB.T1 in cardiomyocytes led to cardiomyopathy (Fulgenzi et al. 2015) , suggesting that BDNF-TrkB.T1 signalling plays an important role in normal cardiac function. Altogether, these results suggest that FNDC5, BDNF and TrkB are differently regulated in different areas of the LV post MI. In the infarct area, FNDC5 protein increased, whereas mBDNF protein was decreased, but TrkB.T1 protein increased. FNDC5 protein was not correlated with BDNF mRNA or protein, suggesting that in the heart, FNDC5 does not activate BDNF, as reported in neurons (Wrann et al. 2013) . Factors contributing to this differential regulation are unclear, and the possible functional implications require further study. Exercise training post MI may decrease plasma Ang II and reduce pro-inflammatory cytokines and decrease cardiomyocyte apoptosis in the LV (Gomes-Santos et al. 2014; Lu et al. 2015; Puhl et al. 2015) . Consistent with other studies (Xu et al. 2008a,b) , exercise training markedly attenuated the decrease in EF and increase in LVEDP, indicating that exercise training improved cardiac function post MI. Exercise training significantly increased mBDNF protein in the non-infarct area, and mBDNF protein was positively correlated with EF and negatively correlated with LVEDP, suggesting that the exercise training-induced increase in BDNF might contribute to the improvement of cardiac function. This would be consistent with studies by Okada et al. (2012) and Hang et al. (2015) showing that deletion of cardiac TrkB increased fibrosis and further decreased EF, whereas intramyocardial or peripheral administration of BDNF normalized the decrease in EF and increase in fibrosis.
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Further studies can address this in rats by chronic blockade of TrkB receptors. Several mechanisms might contribute to the exercise-induced increase in cardiac mBDNF. Cardiac FNDC5 mRNA and protein did not change, and cardiac FNDC5 therefore probably did not contribute to the increase in cardiac mBDNF protein.
Another possible regulator of cardiac BDNF may be pro-and anti-inflammatory cytokines, such as TNF-α and IL-1β (pro-) and IL-10 (anti-). Pro-inflammatory cytokines reduced BDNF mRNA and protein expression in rat brain (Lapchak et al. 1993; Guan & Fang, 2006) . Given that exercise training attenuates the increase in TNF-α, IL-1β and IL-6 post MI (Puhl et al. 2015) and increases IL-10 ( Kesherwani et al. 2015) in the LV, it is possible that the increase in mBDNF is mediated by a decrease in these pro-inflammatory cytokines and an increase in anti-inflammatory cytokines. Finally, as cardiac BDNF mRNA did not increase in parallel with protein, one cannot exclude the possibility that uptake from the circulation might play a role (Knaepen et al. 2010) . The brain is a major source of circulating BDNF during exercise (Rasmussen et al. 2009; Seifert et al. 2010) . Acute exercise increases circulating BDNF transiently, and an increase in resting plasma BDNF may occur after chronic exercise training (Knaepen et al. 2010; Seifert et al. 2010) . In the present study, plasma BDNF concentrations still showed a modest (P = 0.06) increase ß48 h after the last exercise session.
In conclusion, after MI, FNDC5 protein increases and mBDNF protein decreases in the infarct area of the LV. Exercise training increases mBDNF in skeletal muscle and the non-infarct area of the LV, without changes in mRNA level, suggesting that post-transcriptional mechanisms contribute to the increase in mBDNF induced by exercise training. The increases in mBDNF in the LV and skeletal muscle induced by exercise training are not associated with changes in FNDC5, indicating that FNDC5 does not contribute to the changes in mBDNF levels in the heart or skeletal muscle. Increasing cardiac and skeletal muscle mBDNF-TrkB signalling may represent a good therapeutic target to attenuate development of HF and skeletal muscle dysfunction post MI.
